Zura Bio Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Rob Lisicki
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | n/a |
| Management average tenure | 1.8yrs |
| Board average tenure | 1.6yrs |
CEO
Rob Lisicki (57 yo)
less than a year
Tenure
Mr. Robert Lisicki, also known as Rob, has been Chief Executive Officer and Director of Zura Bio Limited since April 08, 2024. He was President and Chief Operating Officer of Zura Bio Limited since joining...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Director | no data | US$10.75m | 3.73% $ 6.1m | |
| Chief Financial Officer | 1.8yrs | US$3.47m | 0.79% $ 1.3m | |
| Chief Legal Officer & Corporate Secretary | 2.3yrs | US$4.87m | 0.19% $ 307.7k | |
| CEO & Director | less than a year | no data | no data | |
| Chief Technology Officer | 1.8yrs | no data | 0% $ 0 | |
| Chief Human Resources Officer | 1.8yrs | no data | no data | |
| Head of Business Development | no data | US$153.90k | no data | |
| Chief Medical Officer & Head of Development | 1.1yrs | no data | 0.0049% $ 8.0k |
1.8yrs
Average Tenure
51yo
Average Age
Experienced Management: ZURA's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder & Director | 1.8yrs | US$10.75m | 3.73% $ 6.1m | |
| CEO & Director | less than a year | no data | no data | |
| Independent Director | 1.8yrs | US$194.33k | 0% $ 0 | |
| Independent Director | 1.8yrs | US$184.33k | 0% $ 0 | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Chairman | 1.8yrs | US$11.19m | 0.62% $ 1.0m | |
| Independent Director | 1.8yrs | US$186.33k | 0% $ 0 | |
| Independent Director | 2.8yrs | US$903.82k | 0% $ 0 | |
| Independent Director | 1.5yrs | US$47.08k | 0% $ 0 | |
| Non-Executive Independent Director | 1.1yrs | US$8.07k | 0.15% $ 250.0k | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
1.6yrs
Average Tenure
56yo
Average Age
Experienced Board: ZURA's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/29 12:06 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Zura Bio Limited is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joshua Schimmer | Cantor Fitzgerald & Co. |
| Matthew Barcus | Chardan Capital Markets, LLC |
| Daniil Gataulin | Chardan Capital Markets, LLC |